Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Cash Flow Reinvestment Rate
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting CN¥3.59 Million (capex CN¥3.59 Million ) from operating cash flow of CN¥294.76 Million. See 002424 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Guizhou Bailing Group Pharmaceutical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Guizhou Bailing Group Pharmaceutical Co (002424) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Guizhou Bailing Group Pharmaceutical Co Ltd. See how financially flexible is Guizhou Bailing Group Pharmaceutical Co to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥131.71 Million | CN¥748.72 Million | CN¥125.24 Million | ▼ -99.1% |
| 2024 | 20.46x | CN¥184.60 Million | CN¥9.02 Million | CN¥42.02 Million | ▲ +1892.6% |
| 2023 | 1.03x | CN¥129.16 Million | CN¥125.77 Million | CN¥104.12 Million | ▲ +245.6% |
| 2022 | 0.30x | CN¥149.20 Million | CN¥502.15 Million | CN¥68.45 Million | ▼ -83.6% |
| 2021 | 1.81x | CN¥587.80 Million | CN¥324.92 Million | CN¥425.73 Million | ▲ +318.8% |
| 2020 | 0.43x | CN¥100.12 Million | CN¥231.78 Million | CN¥90.02 Million | ▼ -65.6% |
| 2019 | 1.26x | CN¥587.02 Million | CN¥467.41 Million | CN¥121.91 Million | ▼ -55.3% |
| 2017 | 2.81x | CN¥224.68 Million | CN¥79.88 Million | CN¥144.68 Million | ▲ +321.2% |
| 2016 | 0.67x | CN¥311.62 Million | CN¥466.62 Million | CN¥159.34 Million | ▲ +22.7% |
| 2015 | 0.54x | CN¥224.99 Million | CN¥413.23 Million | CN¥121.04 Million | ▲ +123.4% |
| 2014 | 0.24x | CN¥96.49 Million | CN¥395.83 Million | CN¥96.49 Million | ▼ -61.1% |
| 2013 | 0.63x | CN¥88.74 Million | CN¥141.76 Million | CN¥88.74 Million | ▼ -93.2% |
| 2012 | 9.23x | CN¥180.16 Million | CN¥19.52 Million | CN¥180.16 Million | ▲ +865.3% |
| 2011 | 0.96x | CN¥193.07 Million | CN¥201.90 Million | CN¥193.07 Million | ▲ +446.8% |
| 2009 | 0.17x | CN¥21.91 Million | CN¥125.31 Million | CN¥21.91 Million | — |